跳至主要内容
临床试验/NCT00328705
NCT00328705已完成不适用

D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

Medtronic Cardiac Rhythm and Heart Failure5 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2006年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65
试验地点
5
主要终点
Ventricular fibrillation (VF) detection time

研究概览

简要总结

This is an acute, prospective, multi-center, non-randomized, investigational device exemption (IDE) clinical study.

详细描述

The purpose of this study is to confirm the performance of new sensing circuitry, and to confirm the performance of a Ventricular Capture Management feature in subjects with implantable cardioverter defibrillator (ICD) leads connected to an external pacemaker/defibrillator.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients who are scheduled for implantation or replacement of an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device
  • •Patients must have or receive Medtronic transvenous atrial and ventricular leads in association with the scheduled device implant or replacement.

排除标准

  • •Patients who have 3rd degree heart block, as assessed by the investigator
  • •Patients who have a mechanical tricuspid heart valve
  • •Patients who have received an investigational new drug or device, or are currently enrolled in a clinical study for a new indication of an approved drug or device

结局指标

主要结局

Ventricular fibrillation (VF) detection time

Ventricular Capture Management accuracy

次要结局

未报告次要终点

研究者

发起方
Medtronic Cardiac Rhythm and Heart Failure
申办方类型
Industry

研究点 (5)

Loading locations...

相似试验